Podcast appearances and mentions of Ian Harris

Ian Harris is the NAEA Propertymark Vice President and the Regional Sales and Marketing Manager for Watsons Residential Sales in Norfolk. In the winter of 2024, he dropped by the WatkinSofa to chat about Mental Health in Estate and Letting Agency.

Ian Harris is the NAEA Propertymark Vice President and the Regional Sales and Marketing Manager for Watsons Residential Sales in Norfolk. In the winter of 2024, he dropped by the WatkinSofa to chat about whether ROPA is a threat to the Estate Agency industry or not.

Ian Harris is the NAEA Propertymark Vice President and the Regional Sales and Marketing Manager for Watsons Residential Sales in Norfolk. In the winter of 2024, he dropped by the WatkinSofa to chat all things Estate Agency and whether or not a Propertymark membership is worth the cash.

Ian Harris is the NAEA Propertymark Vice President and the Regional Sales and Marketing Manager for Watsons Residential Sales in Norfolk. In the winter of 2024, he dropped by the WatkinSofa to chat all things Estate Agency, as well as his 40 year Estate Agency story.

Interview with Ian Harris, CEO and President, Outcrop SilverOur previous interview: https://www.cruxinvestor.com/posts/outcrop-silver-tsxvocg-leveraging-high-grade-silver-in-colombia-in-growing-global-demand-5930Recording date: 3rd of March, 2025Outcrop Silver is developing its flagship Santa Ana project in Colombia, positioned as one of the world's highest-grade primary silver projects. With 75% of its value derived from silver and exceptional recovery rates of 96-99% for both silver and gold, the project represents a rare opportunity for investors seeking pure silver exposure.The company has secured significant backing from prominent silver investor Eric Sprott, who holds a 19.9% stake—the maximum allowable before triggering takeover provisions. According to CEO Ian Harris, this makes Outcrop among Sprott's top five investments last year despite the company's relatively small size.For 2025, Outcrop has allocated an ambitious $12 million exploration budget to drill 24,000 meters using two drilling rigs. The company employs a systematic approach to target prioritization, analyzing factors such as grade, thickness, success rate, and strike length to calculate potential ounces and drilling costs. Their goal is to convert targets to resources at approximately 50 cents per ounce, well below their market valuation."The goal is to do it at around 50 cents... basically our cost to convert to resource, and our valuation is much higher than that number," Harris explained. "We are putting in a plan that securely will create more value for less money than we're spending."Harris emphasized the advantages of being a true primary silver project, which creates greater leverage to silver prices. He noted silver's potential for explosive price movements compared to other metals: "If I said do you believe that it's possible that silver could double in price this year, the argument would be yes. Is there a possibility of copper going two times this year? No."The company sees potential for industry consolidation among the small peer group of quality primary silver companies to improve capital access. Harris suggested combining companies with complementary attributes could be beneficial in the current capital-constrained environment.Outcrop operates within a unique silver market characterized by structural supply-demand imbalances. Primary silver mines represent less than 25% of global production, with the majority coming as byproducts from base metal operations. Meanwhile, industrial demand continues growing, with solar panel manufacturing accounting for approximately 25% of consumption.With Colombia's presidential election approaching in 14 months, the company is well-positioned to benefit from potential renewed interest in mining investment while advancing its high-grade project toward resource expansion.Learn more: https://www.cruxinvestor.com/companies/outcrop-silver-goldSign up for Crux Investor: https://cruxinvestor.com

Ian Harris is the NAEA Propertymark Vice President and the Regional Sales and Marketing Manager for Watsons Residential Sales in Norfolk. In the winter of 2024, he dropped by the WatkinSofa to chat about Estate Agency versus Solicitors.

Welcome to another episode of Predictable B2B Success! Today, we're delving into the transformative world of AI-driven podcasting with the innovative Ian Harris of Pulse Podcasts. Have you ever wondered how AI can reshape content creation and facilitate seamless engagement? Ian is here to unravel the mysteries. Specializing in problem-solving through first principles, Ian has revolutionized how businesses approach content, pushing them beyond narrow confines to explore broader horizons. We'll uncover how Pulse Podcasts leverages large language models to curate engaging news and convert written content into captivating audio experiences. Discover the intricate balance between human touch and AI efficiency in creating natural-sounding, top-quality podcasts that don't just inform but enthrall. Vinay Koshy and Ian dive deep into the challenges and triumphs of this evolving industry, revealing strategies for harnessing podcasts as powerful branding tools. Whether you're intrigued by the future of AI in content creation or looking to enhance your marketing arsenal, this episode promises a wealth of insights. Join us as we explore how AI can make podcast production cost-effective, broaden audience reach, and build enduring customer relationships. Don't miss this chance to reimagine your content strategy with Pulse Podcast's visionary approach! Some areas we explore in this episode include: Problem-Solving Using First Principles: Utilizing first principles to innovate and solve business challenges.Pulse Podcast System: Using large language models, transitioning from a text-to-audio engine to a content curation system.Script Development Approach: The multi-step process of refining content into engaging podcast scripts.AI in Podcast Production: Use of AI for fully automated podcasts and hybrid interviews, reducing production costs while maintaining quality.Role of Podcasts in Content Strategy: Podcasts as a branding tool that builds long-term relationships rather than immediate lead generation.Client Acquisition Strategies: Effective methods like conference speaking, podcast advertising, and leveraging customer referrals.Cost-Effectiveness of AI-Powered Podcasts: Significant cost reductions with high-quality AI-produced podcasts.Natural-Sounding Text-to-Speech: Advances in text-to-speech technology for authentic and engaging audio content.Exploring New Business Opportunities: Strategic expansion into adjacent markets, like local governments, using podcasts.Future of Podcasting and AI: AI's supportive role in podcasting with humans steering branding and messaging.And much, much more ...

Get the inside track on the Vintners Company with Ian Harris MBE. The livery company dates back 660 years and is very much thriving today in its support of the wine industry.

il mio nuovo corso sugli infortuni in palestra: https://www.calabretto…→ il mio libro “powerlifting dalla teoria alla pratica”: https://amzn.eu/d/6QK8B62 → Visita il mio sito: https://www.calabretto…→ Leggi tutti gli articoli gratuiti nel mio blog: https://www.calabretto… → Info su coaching online, consulenze dal vivo e online, programmi di allenamento personalizzati, info sul corso […]

As we count down to Top Shelf Partners' Commodities Global Expo 2024, happening from October 20 to 22 at the Four Seasons Fort Lauderdale, we're excited to sit down with Libero Copper and Gold's (TSXV: LBC | OTCQB: LBCMF) President & CEO, Ian Harris. The company is focused on unlocking the value of the Mocoa copper-molybdenum porphyry deposit in Putumayo, Colombia, with an emphasis on copper, a critical mineral for electrification and renewable energy.In this interview, Ian discusses Libero Copper and Gold's mineral exploration at the Mocoa Project, market opportunities arising from the growing global demand for copper, and the strategies the company intends to pursue to build value.Harness the power of copper for a greener tomorrow with Libero Copper and Gold. Learn more: https://liberocopper.com/Don't miss out on the opportunity to connect with Libero Copper and Gold. Register for the Commodities Global Expo 2024 today: https://topshelf-partners.com/Watch the full YouTube interview here: https://youtu.be/71UJ6aVPaA4And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

This week, Ian Harris joins Matt and the gang in the CrossTalk Studio. Check it out. And, don't forget to set a reminder for the next episode. We publish every other Monday. We'd hate for you to miss it!

Send us a textEpisode 238: AI-Generated Podcasts: The Future of Content Creation with Ian HarrisKendra talks imperfect marketing with Ian Harris, an expert in product and technology strategy who has helped some of the largest companies on the planet. Ian is here to help us unpack the meaning of technology change, especially around AI, content creation, and the future of business.Topics covered in today's conversation include:The value of using podcasts for marketingChallenges of consistently producing podcast contentHow AI can transform existing content into podcast scriptsThe importance of maintaining brand voice and personality in AI-generated contentOvercoming language and accent challenges in AI-generated podcastsMaking podcasting more cost-effective for smaller businessesConnect with Ian Harris:Pulse PodcastsJoin us every Tuesday and Thursday for more insights on marketing strategies and building successful businesses. Don't forget to rate and subscribe! Looking to leverage AI? Want better results? Want to think about what you want to leverage?Check and see how I am using it for FREE on YouTube. From "Holy cow, it can do that?" to "Wait, how does this work again?" – I've got all your AI curiosities covered. It's the perfect after-podcast snack for your tech-hungry brain. Watch here

Interview with Ian Harris, President & CEO of Outcrop Silver.Our previous interview: https://www.cruxinvestor.com/posts/top-silver-development-projects-offer-exposure-to-rising-industrial-demand-5453Recording date: 10th September 2024Outcrop Silver (TSXV:OCG) presents an intriguing opportunity for investors seeking exposure to the silver market through a high-grade exploration project. The company's flagship Santa Ana project in Colombia stands out as one of the highest-grade undeveloped silver projects globally, offering significant leverage to silver prices and substantial exploration upside.Santa Ana currently boasts a resource of 37 million ounces of silver equivalent, with 75% of its resource value in silver. This high silver content distinguishes Outcrop from many peers, positioning it as a relatively pure-play silver company. CEO Ian Harris emphasizes, "At 75% of the value, we're highly leveraged," highlighting the company's strong exposure to silver price movements.The company's primary strategy focuses on expanding its resource base through methodical exploration of multiple veins. This approach aims to de-risk exploration efforts by testing numerous targets to identify those likely to add the most ounces per meter drilled. Outcrop's goal is ambitious, with potential to double or even triple the current resource size.Beyond exploration, Outcrop is considering various development scenarios for Santa Ana. The project's high grade, coupled with favorable metallurgy, positions it well for potential future production. The company is exploring options ranging from larger-scale development to smaller pilot production, providing flexibility to adapt to market conditions.A key strength of Outcrop's approach is its focus on community relations. The company has made significant efforts to build positive relationships with local communities, which is crucial for the long-term success of mining projects. This strategy helps mitigate political and permitting risks, potentially smoothing the path to development.The broader silver market presents a compelling backdrop for Outcrop's efforts. Growing industrial demand, particularly from the renewable energy sector, is driving silver consumption. This demand growth, coupled with limited supply expansion in the silver mining industry, could lead to favorable pricing dynamics.For investors, Outcrop offers several attractive features: a high-grade resource with exploration upside, strong leverage to silver prices, development optionality, and a presence in an increasingly mining-friendly jurisdiction. The company's experienced management team, led by CEO Ian Harris who brings substantial mining experience in South America, further strengthens the investment case.As with any junior mining investment, risks remain. These include exploration uncertainty, future funding requirements that could lead to dilution, exposure to volatile metal prices, and potential political and regulatory challenges in Colombia.In conclusion, Outcrop Silver represents an interesting opportunity for investors bullish on silver and comfortable with the risk-reward profile of exploration-stage companies. The company's high-grade Santa Ana project, coupled with its methodical approach to resource expansion and consideration of various development scenarios, provides multiple avenues for potential value creation. As the global demand for silver continues to grow, companies with high-quality silver assets like Santa Ana may be well-positioned to benefit.View Outcrop Silver's company profile: https://www.cruxinvestor.com/companies/outcrop-silver-goldSign up for Crux Investor: https://cruxinvestor.com

Ikke den mest mundrette titel, men nu fik undertegnede lov at besøge Robin Christensen, og så skulle vi hele vejen rundt. Gæst: Robin Christensen, Biostatistiker, Professor mm.Robin er interessant at tale med, både fordi han er skarp og underholdende, men for mig primært fordi han er meget vidende udi reumatologi, dog med et helt andet syn på tingene end en læges.Jeg lagde op til en snak om antiinflammatorisk kost; en spændende trend, der har verseret i vel nok en decade som etablere fænomen. I den forbindelse kommer vi også omkring blandt andet kosttilskud og carnivor diæt samt kød og evidensen for sundhedsricisi herved.Efter kostdelen står den på en snak om placebo, for at blive klogere på den størrelse. Robin får chancen for at forklare sit syn på placebo, og hvorfor placebo burde omdøbes.Til sidst står den på statistik, nærmere en diskussion omkring p-værdier - noget man forhåbentligt kan få gavn af, skulle man selv sysle med noget forskning, forskningslæsning, fortolkning, reviewing og hvad har vi.LINKS:ASA's statement on p-values:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187603/Faste + vegetar:https://www.tandfonline.com/doi/abs/10.1080/030097401750065256Kød og sundhed: https://pubmed.ncbi.nlm.nih.gov/31569217/https://pubmed.ncbi.nlm.nih.gov/31569219/https://pubmed.ncbi.nlm.nih.gov/31569235/Placebo bøger af Ian Harris:https://www.plusbog.dk/surgery-the-ultimate-placebo-professor-ian-harris-ian-harris-9781742234571?affiliate=6433&gad_source=291197&gad_source=1&gclid=CjwKCAjwvvmzBhA2EiwAtHVrb-OK_qoKGuHB2dj8dTz3L57coTLfKEeOolkUqfKwcmob0vRrK5E-xxoCr20QAvD_BwEhttps://www.saxo.com/dk/hippocrasy-how-doctors-are-betraying-their-oath-how-doctors-are-betraying-their-oath-rachelle-buchbinder-ian-harris_haeftet_9781742237350?gad_source=1&gclid=CjwKCAjwvvmzBhA2EiwAtHVrb0YjV9rOFVYkepfVOpfb-calCIQVcl80VH_fhIJ8HPJpwEJXNT9xthoC5FkQAvD_BwE

Ian Harris, President and CEO of Outcrop Silver & Gold Corporation (TSXV: OCG) (OTCQX: OCGSF), joins us to introduce the company, project, team, and financial metrics for this exploration company focused on expanding resources and derisking its flagship Santa Ana high-grade silver project in Colombia.   We start off discussing the Santa Ana Project and the 37 million silver equivalent ounces in place, and that the majority of metals endowment is primary silver with a gold co-credit, as opposed to many silver projects that are really more base-metals dominant.  Ian also outlines the derisking work through metallurgical testing that has shown fantastic recovery rates, and points out that they have the trifecta of high metals grades, good recovery rates, and good payables (without many smelter penalties).    The key focus this year into next will be showing meaningful growth of the resources at Santa Ana, with the goal to double, and eventually triple the resources in place, before moving into economic studies. The company will be averaging 2,000 meters in drilling per month through the end of the year.   In addition to all the exploration and development work going on at the project, the team behind Outcrop Silver also has a commitment to responsible mining practices and community engagement, underscoring their approach to sustainable development. Ian highlights the strength of the management team and board, and points out that their expertise in navigating complex geological and market conditions enabling them to consistently identify and capitalize on opportunities to enhance shareholder value. With a deep understanding of the Colombian mining landscape and a track record of successful exploration, Outcrop Silver is poised to transform the Santa Ana project into a significant silver producer, contributing positively to the local economy.   If you have any questions for Ian regarding Outcrop Silver & Gold, then please email them in to us at either Fleck@kereport.com or Shad@kereport.com.   Click here to follow the latest news from Outcrop Silver

In this episode of the Radically Genuine Podcast, Dr. Roger McFillin is joined by Dr. Ian Harris, an esteemed orthopedic surgeon in clinical practice in Sydney, Australia. He is a professor of orthopedic surgery with a PhD in evidence based medicine and surgery. He directs a research unit that focuses on outcomes of surgery and has published and presented widely in the field of surgical outcomes. He is the author of “Surgery, The Ultimate Placebo” and co-authored the book “Hippocrasy: How doctors are betraying their oath.”They explore the power of the mind in healing and the implications of placebo effects in surgical outcomes. From knee arthroscopies to spinal fusions, discover how expectations can influence recovery and why some common surgeries may not be as effective as believed. Gain insights into the scientific scrutiny of surgical procedures and the importance of rigorous evidence in medical practices. This conversation challenges conventional medical wisdom and highlights the need for transparency and patient-centered care.Timestamps and Key Points:Introduction (0:00 - 2:25)- Dr. Roger McFillin introduces the podcast and the topic of the placebo effect in medical interventions.- Brief explanation of the placebo effect and its significance in mental health and pain management.Guest Introduction (2:25 - 2:57)- Introduction of Professor Ian Harris, an orthopedic surgeon and professor with a PhD in evidence-based medicine.- Highlight his research focus on surgical outcomes and his books, "Surgery, The Ultimate Placebo" and "Hypocrisy, How Doctors Are Betraying Their Oath."Placebo Effect in Mental Health and Surgery (2:57 - 5:18)- Discussion on how placebo treatments can rival actual drugs in mental health.- Exploration of the placebo effect's impact on invasive medical interventions and surgeries.Understanding Placebo in Surgery (5:18 - 9:20)- Professor Harris explains the definition and confusion around the term "placebo."- Introduction of the concept of non-specific effects and how they relate to surgical outcomes.Scientific Scrutiny of Surgeries (9:20 - 17:25)- Explanation of how rigorous scientific studies (three-arm studies) help to understand the true effectiveness of surgical procedures.- Comparison of active treatment, placebo surgery, and no treatment groups.Surgeon's Perspective and Clinical Decisions (17:25 - 19:53)- Professor Harris shares his journey from a general orthopedic surgeon to an evidence-based practitioner.- Discussion on observational versus experimental evidence in surgery.Examples of Ineffective Surgeries (19:53 - 27:59)- Specific examples of common surgeries with questionable effectiveness, such as arthroscopic knee surgeries and spine fusions.- Mention of geographic variations in surgical rates and the influence of financial incentives.Patient Expectations and Ethical Implications (27:59 - 33:32)- The role of patient expectations in treatment outcomes.- Ethical considerations of using placebo treatments and the importance of informed consent.Challenges in Medical Evidence (33:32 - 41:33)- Discussion on the flawed nature of much medical evidence, as highlighted by Dr. John Ioannidis' research.- The systemic issues in medical training and the influence of pharmaceutical companies on medical guidelines.The Role of Science in Medicine (41:33 - 57:18)- Emphasis on the need for scientific rigor in clinical practice.- The benefits of systems like Australia's Pharmaceutical Benefits Scheme and the limitations of pre-existing medical procedures.Conclusion (57:18 - 59:22)- Key takeaways from the conversation.- Encouragement for medical professionals to provide evidence-based care and for patients to seek informed consent.- Thanking Professor Harris for his insights and promoting his book for further reading.Closing Remarks (59:22 - 59:26)- Dr. McFillin closes the episode with a reminder of the podcast's mission to provide radically genuine conversations on important topics.Note: This podcast episode is designed solely for informational and educational purposes, without endorsing or promoting any specific medical treatments. We strongly advise consulting with a qualified healthcare professional before making any medical decisions or taking any actions.*If you are in crisis or believe you have an emergency, please contact your doctor or dial 911. If you are contemplating suicide, call 1-800-273-TALK to speak with a trained and skilled counselor.RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS—----------

In this episode of The Shoulder Physio Podcast, I am joined by Rachelle Buchbinder and Ian Harris. Rachelle and Ian are academic doctors who still see and treat patients whilst also conducting high quality research. This conversation centres around the concept that modern medical care is sick. Over-treatment, over-diagnosis, junk science, and perverse incentives are just some of the issues plaguing modern medicine. As it happens, Rachelle and Ian have written a book on this exact topic! The book is provocatively titled "Hippocracy: how doctors are betraying their oath" and is available at the link below. I hope you enjoy this episode. Key Resources: 1. Hippocracy: how doctors are betraying their oath. 2. Harris IA, Sidhu V, Mittal R, Adie S. Surgery for chronic musculoskeletal pain: the question of evidence. Pain. 2020 Sep;161 Suppl 1:S95-S103. doi: 10.1097/j.pain.0000000000001881. PMID: 33090742. Cliniko free trial, click here! Shoulder Physio Online Course Connect with Jared and guests: Jared on Instagram: @‌shoulder_physio Jared on Twitter: @‌jaredpowell12 Rachelle on Twitter: @RachelleBuchbin Rachelle on google scholar Ian on google scholar See our Disclaimer here: The Shoulder Physio - Disclaimer

The latest advancements in text-to-voice technology are opening up exciting new business opportunities. Text-to-voice technology is rapidly improving, making it more accessible and effective for various applications. These advancements are enhancing user experiences and creating new avenues for businesses to explore and innovate. One significant opportunity lies in customer service. Companies can implement more natural and responsive virtual assistants with enhanced text-to-voice models. These assistants can handle customer inquiries efficiently, reducing the need for human intervention and improving service availability. Another promising area is in content creation. Businesses can now generate high-quality audio content from text with ease. This is particularly beneficial for creating podcasts, audiobooks, and voiceovers for videos, enabling companies to reach wider audiences and diversify their content offerings. In the education sector, text-to-voice technology is a valuable tool. It aids in developing accessible learning materials for students with visual impairments or reading difficulties. Additionally, it supports language learning by providing precise and accurate pronunciations, enhancing the overall educational experience. Moreover, the entertainment industry can leverage text-to-voice technology to create more immersive experiences. From voice acting in video games to narrating stories in augmented reality applications, the potential uses are vast and continually expanding. As text-to-voice technology evolves, its applications become more diverse and impactful. Businesses across various sectors can harness these advancements to improve their services, create new content, and enhance accessibility. Embracing these opportunities will drive innovation and provide significant competitive advantages in the market. Episode # 138 Today's Guest: Ian Harris, Founder, Pulse Podcasts Ian has started his unique idea to help others capitalize on AI advancements. He launched his product using text-to-voice, assisting brands in offering audio content. Website: Pulse Podcasts Twitter/X: Pulse Podcasts What Listeners Will Learn: How to Use AI for Recording and Presenting Podcasts Step-by-step guidance on transforming written content into engaging audio  Whether and how to inform your audience that AI generates the voice An overview of the technologies used, including the origins and evolution of the AI tools employed. Explanation of the specific language models (LLMs) used and how they help deliver content effectively to the audience. Tips and suggestions for those interested in starting a career or project in AI How can the idea be validated and determine if there is a market for an AI-driven product?  Practical strategies for launching and marketing a new AI-based product. Resources: Pulse Podcasts

Send us a Text Message.How is AI transforming the way we listen to podcasts? On this episode of "Politically High Tech," we welcome our second Australian guest, Ian Harris, for an enlightening conversation about the future of podcasting. Ian, the CEO of Pulse Podcasts, unravels the limitations of traditional marketing channels like social media and newsletters, spotlighting the enduring charm of audio content. With over 400 million podcast listeners worldwide, discover how AI can elevate the podcasting experience, making it more compelling and accessible for our busy lives.Join us as we dive into the technical marvels of AI in podcasting. Learn how AI not only enhances audio quality by eliminating background noise but also refines accents to create seamless and authentic listening experiences. Ian and I share personal anecdotes about the quirks of AI-generated voices and emphasize the critical need for responsible AI development. Despite tech advancements, we underscore the importance of maintaining the authenticity and spontaneity that make podcasts so engaging.But the excitement doesn't stop there. Imagine personalized Spider-Man movies or real-time interactive gaming experiences powered by AI. We explore these thrilling future possibilities and discuss how AI-generated video could revolutionize media consumption. Finally, we shine a spotlight on Pulse Podcasts and their innovative approach to transforming written content into captivating audio. Tune in to grasp the endless potential of AI in reshaping the podcasting landscape and beyond.Follow Ian Harrishttps://www.pulsepodcasts.com/If you want to be a guest on my podcast. Join PodMatch by clicking on the link provided. https://www.joinpodmatch.com/politically-high-techSupport the Show.Follow your host atYouTube and Rumble for video contenthttps://www.youtube.com/channel/UCUxk1oJBVw-IAZTqChH70aghttps://rumble.com/c/c-4236474Facebook to receive updateshttps://www.facebook.com/EliasEllusion/Twitter (yes, I refuse to call it X)https://x.com/politicallyht

A new MP3 sermon from Let The Bible Speak is now available on SermonAudio with the following details: Title: LTBS TV Program 292 Subtitle: LTBS TV Broadcast Speaker: Rev. Ian Harris Broadcaster: Let The Bible Speak Event: TV Broadcast Date: 6/12/2024 Bible: Hebrews 8:6-13 Length: 28 min.

GUEST OVERVIEW: Ian Harris is a Musician & Ex-Reform/UKIP Candidate. 

Interview with Glenn Jessome, President & CEO of Silver Tiger Metals Inc., and Ian Harris, President & CEO of Outcrop Silver & Gold Corp.Recording date: 30th May 2024*Silver Poised to Shine as Supply Deficit Meets Industrial Demand Surge*Silver prices have rallied over the past year, breaking above $30 per ounce as demand from industrial users and investors accelerates. The fundamentals driving this rally appear sustainable, making silver an attractive option for investors seeking precious metals exposure.At the heart of the bull case for silver is a growing supply deficit. Annual demand for silver is projected to reach 1.2 billion ounces, while total supply from mining and recycling is estimated at just 800 million ounces, leaving a shortfall of 400 million ounces. This structural imbalance seems likely to persist and possibly worsen in the coming years.Demand for silver is surging, driven primarily by its growing use in industrial applications. Silver is a critical component in photovoltaic (PV) cells used in solar panels, and this sector's demand for the metal has grown by over 60% to 200 million ounces per year. With the transition to renewable energy accelerating globally, solar-related demand for silver is expected to continue rising. Newer solar technologies like heterojunction cells are even more silver-intensive.Other key sources of industrial demand include the automotive sector, where silver's use is doubling as electric vehicles gain market share, and electronics, where silver's superior electrical conductivity makes it essential for everything from 5G networks to data centers. Even at much higher prices, these industrial users are unlikely to substitute away from silver, as it is often a small portion of their overall costs but critical to performance.On the supply side, the outlook is increasingly constrained. Only about 30% of annual silver production comes from primary silver mines, with the remainder as a byproduct of base metals and gold mining. The number of primary silver mines globally is projected to decline from 51 currently to just 38 by 2028. Discovering and developing new, economically viable silver deposits is extremely challenging. According to Glenn Jessome, CEO of Silver Tiger Metals, the odds of an early-stage exploration project becoming a producing mine are less than 1 in 10,000.The geopolitical backdrop also appears to be shifting in a more favorable direction for silver mining. Latin America is a key producing region, particularly Mexico and countries in South America. In Mexico, a new government is expected to adopt more pro-mining policies after elections in June. Meanwhile, in South America, the growing precedent of left-leaning leaders successfully implementing pro-mining agendas to drive growth is improving the industry's long-term prospects.For investors looking to gain exposure to the silver rally, high-grade development projects in stable jurisdictions may offer the most attractive risk/reward. Attributes to look for include: strong project economics at current prices, experienced management teams with track records of success, and the potential to significantly expand resources through exploration. Companies with these features are best positioned to bring new production online to meet rising demand.In a bull market for silver, producers tend to trade at high valuations, often approaching $1 billion or more, despite relatively limited output. Development-stage projects at earlier phases can offer similar exposure with much greater upside potential. As an example, Silver Tiger Metals is advancing a project with robust economics including an after-tax NPV of $287 million at $22 silver, which is now projected to reach $450 million at spot prices. Its market cap is just over $100 million, implying plenty of scope for appreciation as the company moves toward production.While the price of silver can be volatile, the current rally appears well-supported by fundamental supply and demand factors. Industrial demand is likely to continue growing, while supply increases will be constrained by the naturally limited number of viable silver deposits. This points to the potential for an ongoing structural deficit in the silver market, which should support rising prices over time. Investors can participate by carefully selecting high-quality silver development projects with strong management teams and assets in attractive jurisdictions.Headline for Investors:—Learn more: https://cruxinvestor.comSign up for Crux Investor: https://cruxinvestor.com

In this episode, we dive deep into the transformative power of artificial intelligence with our guest, Ian Harris. An experienced technology professional, Ian unpacks how AI revolutionizes customer service by understanding sentiment and handling frustrations, ultimately reshaping call center operations. He explores the game-changing impact of AI in software development in DevOps, emphasizing its role in enhancing code reviews and pull requests and automating mundane tasks, freeing up human creativity. Joe and Ian also delve into the practical side of AI in business, discussing powerful tools like Google's Gemini models for data processing and OpenRouter for comparing AI model responses. The conversation doesn't shy away from the challenges, including data security concerns and the need to keep pace with rapid advancements in AI from major players like Google, Amazon, and OpenAI. Whether you're keen on understanding AI's role in communication efficiency, or its potential in creating cost-effective, high-quality podcasts, this episode is packed with insights that you won't want to miss! Try out SmartBear's Bugsnag for free, today. No credit card required. https://links.testguild.com/bugsnag

Welcome back to the Digging Deep ATVMX Podcast! In this episode, we dive into the action from Echeconnee, marking its triumphant return to the ATV Motocross National Championship after nine long years. Returning to this iconic Georgia facility brought a wave of nostalgia, as it had been a cornerstone of the ATV Nationals for years. Join us as we relive the action, covering the weekend's most thrilling moments with insights from Ian Harris of SSI Decals. Plus, we're joined by special guest Kevin Saar, who shares his experience of clinching a big Pro-Am victory over the weekend. Tune in to this episode for an in-depth review of Round 3 at Echeconnee and more. Thanks for joining us as we DIG DEEP into the world of ATV motocross! Enjoy the ride!Support the Show.

In this conversation, Mark Kargela interviews Ian Harris, an orthopedic surgeon and researcher, about the challenges and problems in healthcare. Ian discusses his journey from being a practicing surgeon to becoming interested in the scientific method and evidence-based medicine. He talks about the resistance he has faced in challenging the status quo and the difficulties in changing the way surgeons think. They also discuss the placebo response in surgery, the blurring of normal and disease states in healthcare, and the overuse of procedures like spinal fusion and regenerative medicine. Ian shares his projects on placebo studies for rotator cuff repair and spine fusion, which aim to provide high-quality evidence to change practice.TakeawaysThe scientific method and evidence-based medicine are crucial in improving healthcare practices.Surgeons often face resistance when challenging the status quo and trying to change the way they think.The placebo response in surgery is complex, and contextual factors play a significant role.The blurring of normal and disease states in healthcare leads to unnecessary interventions and medicalization of normal conditions.Procedures like spinal fusion and regenerative medicine are often overused despite limited evidence of their effectiveness.Placebo studies for rotator cuff repair and spine fusion aim to provide high-quality evidence to guide practice.Books (Affiliate Links)Surgery: The Ultimate PlaceboHippocrasy: How Doctors are Betraying Their Oath*********************************************************************

GUEST 1 OVERVIEW: Ian Harris is a Musician & Ex-Reform Candidate for Lewes.  GUEST 2 OVERVIEW: Amy Gallagher is a nurse and psychotherapist opposing "woke" NHS policies and CRT, claiming they impact career progress and enforce ideologies. Amy is running for London Mayor 2024.

A new MP3 sermon from Annalong Free Presbyterian Church is now available on SermonAudio with the following details: Title: Peace in Christ Speaker: Rev. Ian Harris Broadcaster: Annalong Free Presbyterian Church Event: Sunday - AM Date: 3/31/2024 Bible: John 20:19-23 Length: 33 min.

Interview with Ian Harris, President & CEO of Outcrop Siver&Gold Corp.Our previous interview: https://www.cruxinvestor.com/posts/outcrop-silver-gold-tsxvocg-unlocking-high-grade-silver-potential-4692Recording date: 3rd March 2024Outcrop Silver & Gold (TSXV:OCG) is advancing one of the highest-grade undeveloped silver projects globally with its flagship Santa Ana asset in Colombia. With 37 million silver equivalent ounces grading over 600 g/t in the current resource, Santa Ana is a true silver play, deriving 75% of its value from the metal.The company is taking an innovative, multi-pronged approach to creating shareholder value. First, aggressive exploration aims to multiply the resource from the current 37 Moz to over 100 Moz silver euivalent. Secondly, Outcrop is looking to develop a small-scale pilot mine to demonstrate the economic and technical viability of the asset while maintaining its exploration upside in the market.CEO Ian Harris emphasized that the exceptionally high-grade nature of Santa Ana, along with the excellent metallurgy, de-links the project from scale and doesn't require that economy of scale to be able to have the margin. Simple flotation recovers over 93% of the silver into a high-grade concentrate, which can be directly smelted to produce saleable silver doré bars without the need for cyanide. This gives Outcrop multiple options to maximize payability.Colombia is shaping up to be an attractive mining jurisdiction with a government eager to encourage development of silver and critical metals projects to diversify from oil and coal. Outcrop's key is strong engagement with local communities, which the pilot mine would foster through training and capacity building.While the current tough market conditions are challenging for junior miners, Outcrop sees a big picture opportunity in silver as solar, EVs, and electrification are expected to be major demand drivers while ongoing economic uncertainty supports silver's safe haven status.In summary, Outcrop Silver & Gold offers investors compelling exposure to a high-grade silver asset being advanced by a highly experienced management team. The company is well-positioned to create value through a hybrid approach of resource expansion and de-risking through a pilot mine. With 75% of the resource value in silver, Outcrop is highly leveraged to a rising silver price environment that appears likely in the coming years based on the macro fundamentals.View Outcrop Silver & Gold's company profile: https://www.cruxinvestor.com/companies/outcrop-silver-goldSign up for Crux Investor: https://cruxinvestor.com

A new MP3 sermon from Annalong Free Presbyterian Church is now available on SermonAudio with the following details: Title: Lessons from the passover Speaker: Rev. Ian Harris Broadcaster: Annalong Free Presbyterian Church Event: Sunday - AM Date: 3/3/2024 Bible: Exodus 12:1-14 Length: 31 min.

Interview with Ian Harris, President & CEO of Outcrop Silver & Gold Corp.Our previous interview: https://www.cruxinvestor.com/posts/outcrop-silver-gold-tsxvocg-step-out-drilling-on-ag-au-veins-in-colombia-3281Recording date: 8th December 2023Outcrop Positioned to Unlock World-Class Silver PotentialOutcrop Silver & Gold stewards a uniquely prospective silver asset in Colombia with newly appointed CEO Ian Harris at the helm boasting pertinent technical and regional expertise to rapidly advance the project. Santana contains 37 million ounces of high-grade silver resources open to immense expansion potential through further drilling of identified mineralized structures.Bonanza Grades ConfirmedExceptionally high silver grades position Santana as a global top-tier deposit. The sulfide-hosted mineralization facilitates excellent recoveries, with direct smelting capable of achieving up to 98% versus only 75% from comparable complex concentrates. The sheer magnitude of silver endowment per tonne constitutes commanding project leverage to any uplift in prevailing silver prices.Resource Growth ImminentWith efficacious veins consistently evidenced across Santana's footprint, the company has currently defined 21 priority drill targets to systematically upgrade and expand resources beyond the present basis of 7 quantified veins. Despite temporary drilling delays in appointing a new contractor, Outcrop maintains a focused regimen calibrating future growth milestones en route to a 100 million-ounce aggregate resource target crucial to fortifying Santana's world-class project status.Compelling Economic ParametersIn parallel with envisaged resource scaling, Outcrop has directed scoping efforts toward a relatively modest pilot plant operational at 50 tonnes per day, capable of demonstrating robust economics even at such diminutive throughput. The venture requires only circa $750,000 in capital expenditure while being able to furnish positive cash flow offsetting approximately 80% of ongoing exploration activity. This establishes a pathway toward de-risking and market re-rating grounded in the tangible creation of value.Silver Market Primed for ResurgenceWhile prevailing precious metals investment sentiment remains tepid, silver fundamentals appear increasingly positive looking out into 2024. The time may prove opportune for allocating exposure to highly responsive silver vehicles. In Outcrop's case, the sheer magnitude of prospective metal at Santana commands superior leverage to any pricing gains in an ascending cycle. The stock consequently warrants consideration among selective junior developer equivalents that offer pronounced sensitivity to silver values.World-Class Pathway ForwardOutcrop Silver & Gold holds dominion over a potentially transcendent silver orebody. The essential parameters of grade, scale, metallurgy and economics are evidenced to world-leading standards. Near-term goals now concentrate on resource upgrading and materially expanding contingencies. Deft project financing design may layer on modest production to realize material value creation. When silver market tailwinds regain strength, Santana is primed to emerge as one of the global top-tier silver development stories, with Outcrop potentially graduating to headline producer status. The current market discounting of assets in this class could pose a pronounced value proposition for investors with appropriate time horizons.—View Outcrop Silver & Gold company profile: https://www.cruxinvestor.com/companies/outcrop-silver-goldSign up for Crux Investor: https://cruxinvestor.com

Say a spritely hello to the cat amongst the medical pigeons, Professor Ian Harris. A lively presence in his field, Ian is a Professor of Orthopaedic Surgery who was inclined to tuck the scalpel in the back of the drawer and instead pose what is proving to be a pertinent question: 'Do these surgeries offer more than just a placebo effect to one's recovery?' Knee arthroscopies, back fusions and cardiac stenting are amongst the common procedures in question with the Prof, yet in our chat, Ian sheds light not just on the lack of evidence around their efficacy, but also highlights the potential risks and adverse consequences. Sure, the placebo effect may have its merits, but is it justifiable against the recovery time, expense and discomfort associated with these invasive surgeries?   SPONSORED BY AED AUTHORITY  Website: www.aedauthority.com.au  PROFESSOR IAN HARRIS Website: www.ianharris.com.au  TIFFANEE COOK Linktree:  https://linktr.ee/rollwiththepunches/ Website: www.rollwiththepunches.com.au LinkedIn:  www.linkedin.com/in/tiffaneecook/ Facebook:  www.facebook.com/rollwiththepunchespodcast/ Instagram:  www.instagram.com/rollwiththepunches_podcast/ Instagram: www.instagram.com/tiffaneeandcoSee omnystudio.com/listener for privacy information.

Outcrop Gold & Silver newly appointed CEO, Ian Harris, joins the podcast for the first time to discuss this year's exploration strategy at the Santa Ana project. The company is working on a 5,000m drill program to test the new and highly prospective La Estrella target, along with the La Linda, Palomos and Murillo targets.

Before anyone sends me a grumpy email about the title of this episode, it's actually the title of the book written by today's two guests. According to Profs lan and Rachelle, "we've ended up with a healthcare system that's one of the greatest threats to human health". This episode presents some mind-blowing info and stats from two of the most-qualified, well-researched and well-respected people I've chatted with on the show. *Professor Rachelle Buchbinder is an Australian NHMRC Senior Principal Research Fellow. She has been the Director of the Monash Department of Clinical Epidemiology since its inception in 2001 and a Professor in the Monash University Department of Epidemiology and Preventive Medicine since 2007. She is a rheumatologist and clinical epidemiologist. *Professor lan Harris is a clinician and researcher based in Sydney. He is an orthopedic surgeon with a clinical interest in trauma care where his practice is based at Liverpool Hospital in southwest Sydney. He is Professor of Orthopedic Surgery at the South Western Sydney Clinical School of UNSW Sydney and Honorary Professor at the School of Public Health, University of Sydney. amazon.comSee omnystudio.com/listener for privacy information.

Why Do 1/3 Of Patients Not Totally Benefit From Weight Loss Surgery? Dr. John Abramson, M.D• https://hcp.hms.harvard.edu/people/john-david-abramson • Book – Sickening Ian Harris, MD • https://med.unsw.edu.au/our-people/ian-harris • Book - Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence Dr. Robert Yoho • http://www.robertyohoauthor.com • Book - Butchered by “Heathcare” Dr. Robert Lustig • http://www.robertlustig.com • Book - Metabolical #BigPharma #AmericanHealthCare #HealthCarePolicy Dr. John Abramson, M.D. is an author and medical doctor and has served as a family physician for over 20 years. His recently release book Sickening  How Big Pharma Broke American Health Care and How We Can Repair It. Is about the inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. John Abramson MD,  He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for over 15 years, where he has taught primary care and currently teaches health care policy. To Contact Dr John Abramson MD go to hcp.hms.harvard.edu/people/john-david-abramson Dr Ian Harris is a practicing orthopedic surgeon, university professor and an acclaimed author of several books including Hippocrasy: How doctors are betraying their oath. Professor Ian Harris is an orthopedic surgeon who works at Liverpool, St George, St George Private and Sutherland Hospitals in Sydney. His academic affiliation is with UNSW, South Western Sydney Clinical School at Liverpool Hospital, in Sydney. In addition to approximately 200 peer-reviewed publications, he also wroteSurgery, The Ultimate Placebo - an eye-opening evaluation of commonly performed surgical operations that have been tested and shown to be no more effective (and arguably worse) than placebo, or that have never even been tested. He suggests we treat new surgical procedures like new drugs, and only pay for those that are part of a trial to find out if they really work. To Contact Dr Harris go to Email: ianharris@unsw.edu.au Dr. Robert Yoho is an author and accomplished retired Los Angeles cosmetic surgeon. His Book, Butchered by “Heathcare”: What to Do About Doctors, Big Pharma, and Corrupt Government Ruining Your Health and Medical Care. Dr Robert Yoho grew up in Kent Ohio. He was an Eagle Scout and a Judo wrestler. Went to Oberlin College and Case Western Reserve Univ. Medical School. In 2019 Dr Yoho retired from his medical and surgical practice. He now is a full time writer and speaker. No longer responsible for patient care he is able to write full time without conflicts of interest. To Contact Dr Robert Yoho go to  robertyohoauthor.com  Dr. Robert Lustig is a The New York Times bestselling author and author of Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine and a Professor of Pediatric Endocrinology at the University of California, San Francisco. Dr. Robert Lustig, a pediatric neuroendocrinologist who has long been on the cutting edge of medicine and science, challenges our current healthcare paradigm which has gone off the rails under the influence of Big Food, Big Pharma, and Big Government. Dr. Lustig has authored 125 peer-reviewed articles and 73 reviews. He has mentored 20 pediatric endocrine fellows, and trained numerous other allied health professionals. He provides endocrinologic support to several protocols of the Children's Oncology Group.  He is the former Chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Pediatric Obesity Practice Guidelines Subcommittee of The Endocrine Society, a member of the Obesity Task Force of the Endocrine Society, a member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration, a member of the Bay Area Board of Directors of the American Heart Association, and a member of the Steering Committee of Health Foods, Healthy Kids of the Culinary Institute of America. He also consults for several childhood obesity advocacy groups. Dr. Lustig lives in San Francisco with his wife Julie and two daughters. Spare time (what little there is) is spent cooking, theater-going, and traveling. To Contact Dr Robert Lustig, M.D.  go to robertlustig.com Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Is Modern Medicine In A State Of Decay From Corruption? Dr. John Abramson, M.D• https://hcp.hms.harvard.edu/people/john-david-abramson • Book – Sickening Ian Harris, MD • https://med.unsw.edu.au/our-people/ian-harris • Book - Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence Dr. Robert Yoho • http://www.robertyohoauthor.com • Book - Butchered by “Heathcare” Dr. Robert Lustig • http://www.robertlustig.com • Book - Metabolical #BigPharma #AmericanHealthCare #HealthCarePolicy Dr. John Abramson, M.D. is an author and medical doctor and has served as a family physician for over 20 years. His recently release book Sickening  How Big Pharma Broke American Health Care and How We Can Repair It. Is about the inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. John Abramson MD,  He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for over 15 years, where he has taught primary care and currently teaches health care policy. To Contact Dr John Abramson MD go to hcp.hms.harvard.edu/people/john-david-abramson Dr Ian Harris is a practicing orthopedic surgeon, university professor and an acclaimed author of several books including Hippocrasy: How doctors are betraying their oath. Professor Ian Harris is an orthopedic surgeon who works at Liverpool, St George, St George Private and Sutherland Hospitals in Sydney. His academic affiliation is with UNSW, South Western Sydney Clinical School at Liverpool Hospital, in Sydney. In addition to approximately 200 peer-reviewed publications, he also wroteSurgery, The Ultimate Placebo - an eye-opening evaluation of commonly performed surgical operations that have been tested and shown to be no more effective (and arguably worse) than placebo, or that have never even been tested. He suggests we treat new surgical procedures like new drugs, and only pay for those that are part of a trial to find out if they really work. To Contact Dr Harris go to Email: ianharris@unsw.edu.au Dr. Robert Yoho is an author and accomplished retired Los Angeles cosmetic surgeon. His Book, Butchered by “Heathcare”: What to Do About Doctors, Big Pharma, and Corrupt Government Ruining Your Health and Medical Care. Dr Robert Yoho grew up in Kent Ohio. He was an Eagle Scout and a Judo wrestler. Went to Oberlin College and Case Western Reserve Univ. Medical School. In 2019 Dr Yoho retired from his medical and surgical practice. He now is a full time writer and speaker. No longer responsible for patient care he is able to write full time without conflicts of interest. To Contact Dr Robert Yoho go to  robertyohoauthor.com  Dr. Robert Lustig is a The New York Times bestselling author and author of Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine and a Professor of Pediatric Endocrinology at the University of California, San Francisco. Dr. Robert Lustig, a pediatric neuroendocrinologist who has long been on the cutting edge of medicine and science, challenges our current healthcare paradigm which has gone off the rails under the influence of Big Food, Big Pharma, and Big Government. Dr. Lustig has authored 125 peer-reviewed articles and 73 reviews. He has mentored 20 pediatric endocrine fellows, and trained numerous other allied health professionals. He provides endocrinologic support to several protocols of the Children's Oncology Group.  He is the former Chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Pediatric Obesity Practice Guidelines Subcommittee of The Endocrine Society, a member of the Obesity Task Force of the Endocrine Society, a member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration, a member of the Bay Area Board of Directors of the American Heart Association, and a member of the Steering Committee of Health Foods, Healthy Kids of the Culinary Institute of America. He also consults for several childhood obesity advocacy groups. Dr. Lustig lives in San Francisco with his wife Julie and two daughters. Spare time (what little there is) is spent cooking, theater-going, and traveling. To Contact Dr Robert Lustig, M.D.  go to robertlustig.com Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Why Angioplasties Are Next To Useless Dr. John Abramson, M.D• https://hcp.hms.harvard.edu/people/john-david-abramson • Book – Sickening Ian Harris, MD • https://med.unsw.edu.au/our-people/ian-harris • Book - Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence Dr. Robert Yoho • http://www.robertyohoauthor.com • Book - Butchered by “Heathcare” Dr. Robert Lustig • http://www.robertlustig.com • Book - Metabolical #BigPharma #AmericanHealthCare #HealthCarePolicy Dr. John Abramson, M.D. is an author and medical doctor and has served as a family physician for over 20 years. His recently release book Sickening  How Big Pharma Broke American Health Care and How We Can Repair It. Is about the inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. John Abramson MD,  He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for over 15 years, where he has taught primary care and currently teaches health care policy. To Contact Dr John Abramson MD go to hcp.hms.harvard.edu/people/john-david-abramson Dr Ian Harris is a practicing orthopedic surgeon, university professor and an acclaimed author of several books including Hippocrasy: How doctors are betraying their oath. Professor Ian Harris is an orthopedic surgeon who works at Liverpool, St George, St George Private and Sutherland Hospitals in Sydney. His academic affiliation is with UNSW, South Western Sydney Clinical School at Liverpool Hospital, in Sydney. In addition to approximately 200 peer-reviewed publications, he also wroteSurgery, The Ultimate Placebo - an eye-opening evaluation of commonly performed surgical operations that have been tested and shown to be no more effective (and arguably worse) than placebo, or that have never even been tested. He suggests we treat new surgical procedures like new drugs, and only pay for those that are part of a trial to find out if they really work. To Contact Dr Harris go to Email: ianharris@unsw.edu.au Dr. Robert Yoho is an author and accomplished retired Los Angeles cosmetic surgeon. His Book, Butchered by “Heathcare”: What to Do About Doctors, Big Pharma, and Corrupt Government Ruining Your Health and Medical Care. Dr Robert Yoho grew up in Kent Ohio. He was an Eagle Scout and a Judo wrestler. Went to Oberlin College and Case Western Reserve Univ. Medical School. In 2019 Dr Yoho retired from his medical and surgical practice. He now is a full time writer and speaker. No longer responsible for patient care he is able to write full time without conflicts of interest. To Contact Dr Robert Yoho go to  robertyohoauthor.com  Dr. Robert Lustig is a The New York Times bestselling author and author of Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine and a Professor of Pediatric Endocrinology at the University of California, San Francisco. Dr. Robert Lustig, a pediatric neuroendocrinologist who has long been on the cutting edge of medicine and science, challenges our current healthcare paradigm which has gone off the rails under the influence of Big Food, Big Pharma, and Big Government. Dr. Lustig has authored 125 peer-reviewed articles and 73 reviews. He has mentored 20 pediatric endocrine fellows, and trained numerous other allied health professionals. He provides endocrinologic support to several protocols of the Children's Oncology Group.  He is the former Chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Pediatric Obesity Practice Guidelines Subcommittee of The Endocrine Society, a member of the Obesity Task Force of the Endocrine Society, a member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration, a member of the Bay Area Board of Directors of the American Heart Association, and a member of the Steering Committee of Health Foods, Healthy Kids of the Culinary Institute of America. He also consults for several childhood obesity advocacy groups. Dr. Lustig lives in San Francisco with his wife Julie and two daughters. Spare time (what little there is) is spent cooking, theater-going, and traveling. To Contact Dr Robert Lustig, M.D.  go to robertlustig.com Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Do Colonoscopies, Mammograms And Statins Save Lives? Dr. John Abramson, M.D• https://hcp.hms.harvard.edu/people/john-david-abramson • Book – Sickening Ian Harris, MD • https://med.unsw.edu.au/our-people/ian-harris • Book - Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence Dr. Robert Yoho • http://www.robertyohoauthor.com • Book - Butchered by “Heathcare” Dr. Robert Lustig • http://www.robertlustig.com • Book - Metabolical #BigPharma #AmericanHealthCare #HealthCarePolicy Dr. John Abramson, M.D. is an author and medical doctor and has served as a family physician for over 20 years. His recently release book Sickening  How Big Pharma Broke American Health Care and How We Can Repair It. Is about the inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. John Abramson MD,  He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for over 15 years, where he has taught primary care and currently teaches health care policy. To Contact Dr John Abramson MD go to hcp.hms.harvard.edu/people/john-david-abramson Dr Ian Harris is a practicing orthopedic surgeon, university professor and an acclaimed author of several books including Hippocrasy: How doctors are betraying their oath. Professor Ian Harris is an orthopedic surgeon who works at Liverpool, St George, St George Private and Sutherland Hospitals in Sydney. His academic affiliation is with UNSW, South Western Sydney Clinical School at Liverpool Hospital, in Sydney. In addition to approximately 200 peer-reviewed publications, he also wroteSurgery, The Ultimate Placebo - an eye-opening evaluation of commonly performed surgical operations that have been tested and shown to be no more effective (and arguably worse) than placebo, or that have never even been tested. He suggests we treat new surgical procedures like new drugs, and only pay for those that are part of a trial to find out if they really work. To Contact Dr Harris go to Email: ianharris@unsw.edu.au Dr. Robert Yoho is an author and accomplished retired Los Angeles cosmetic surgeon. His Book, Butchered by “Heathcare”: What to Do About Doctors, Big Pharma, and Corrupt Government Ruining Your Health and Medical Care. Dr Robert Yoho grew up in Kent Ohio. He was an Eagle Scout and a Judo wrestler. Went to Oberlin College and Case Western Reserve Univ. Medical School. In 2019 Dr Yoho retired from his medical and surgical practice. He now is a full time writer and speaker. No longer responsible for patient care he is able to write full time without conflicts of interest. To Contact Dr Robert Yoho go to  robertyohoauthor.com  Dr. Robert Lustig is a The New York Times bestselling author and author of Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine and a Professor of Pediatric Endocrinology at the University of California, San Francisco. Dr. Robert Lustig, a pediatric neuroendocrinologist who has long been on the cutting edge of medicine and science, challenges our current healthcare paradigm which has gone off the rails under the influence of Big Food, Big Pharma, and Big Government. Dr. Lustig has authored 125 peer-reviewed articles and 73 reviews. He has mentored 20 pediatric endocrine fellows, and trained numerous other allied health professionals. He provides endocrinologic support to several protocols of the Children's Oncology Group.  He is the former Chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Pediatric Obesity Practice Guidelines Subcommittee of The Endocrine Society, a member of the Obesity Task Force of the Endocrine Society, a member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration, a member of the Bay Area Board of Directors of the American Heart Association, and a member of the Steering Committee of Health Foods, Healthy Kids of the Culinary Institute of America. He also consults for several childhood obesity advocacy groups. Dr. Lustig lives in San Francisco with his wife Julie and two daughters. Spare time (what little there is) is spent cooking, theater-going, and traveling. To Contact Dr Robert Lustig, M.D.  go to robertlustig.com Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

A Lot Of Cancer Drugs Were Approved Based On Surrogate Outcomes Dr. John Abramson, M.D• https://hcp.hms.harvard.edu/people/john-david-abramson • Book – Sickening Ian Harris, MD • https://med.unsw.edu.au/our-people/ian-harris • Book - Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence Dr. Robert Yoho • http://www.robertyohoauthor.com • Book - Butchered by “Heathcare” Dr. Robert Lustig • http://www.robertlustig.com • Book - Metabolical #BigPharma #AmericanHealthCare #HealthCarePolicy Dr. John Abramson, M.D. is an author and medical doctor and has served as a family physician for over 20 years. His recently release book Sickening  How Big Pharma Broke American Health Care and How We Can Repair It. Is about the inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. John Abramson MD,  He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for over 15 years, where he has taught primary care and currently teaches health care policy. To Contact Dr John Abramson MD go to hcp.hms.harvard.edu/people/john-david-abramson Dr Ian Harris is a practicing orthopedic surgeon, university professor and an acclaimed author of several books including Hippocrasy: How doctors are betraying their oath. Professor Ian Harris is an orthopedic surgeon who works at Liverpool, St George, St George Private and Sutherland Hospitals in Sydney. His academic affiliation is with UNSW, South Western Sydney Clinical School at Liverpool Hospital, in Sydney. In addition to approximately 200 peer-reviewed publications, he also wroteSurgery, The Ultimate Placebo - an eye-opening evaluation of commonly performed surgical operations that have been tested and shown to be no more effective (and arguably worse) than placebo, or that have never even been tested. He suggests we treat new surgical procedures like new drugs, and only pay for those that are part of a trial to find out if they really work. To Contact Dr Harris go to Email: ianharris@unsw.edu.au Dr. Robert Yoho is an author and accomplished retired Los Angeles cosmetic surgeon. His Book, Butchered by “Heathcare”: What to Do About Doctors, Big Pharma, and Corrupt Government Ruining Your Health and Medical Care. Dr Robert Yoho grew up in Kent Ohio. He was an Eagle Scout and a Judo wrestler. Went to Oberlin College and Case Western Reserve Univ. Medical School. In 2019 Dr Yoho retired from his medical and surgical practice. He now is a full time writer and speaker. No longer responsible for patient care he is able to write full time without conflicts of interest. To Contact Dr Robert Yoho go to  robertyohoauthor.com  Dr. Robert Lustig is a The New York Times bestselling author and author of Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine and a Professor of Pediatric Endocrinology at the University of California, San Francisco. Dr. Robert Lustig, a pediatric neuroendocrinologist who has long been on the cutting edge of medicine and science, challenges our current healthcare paradigm which has gone off the rails under the influence of Big Food, Big Pharma, and Big Government. Dr. Lustig has authored 125 peer-reviewed articles and 73 reviews. He has mentored 20 pediatric endocrine fellows, and trained numerous other allied health professionals. He provides endocrinologic support to several protocols of the Children's Oncology Group.  He is the former Chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society, a member of the Pediatric Obesity Practice Guidelines Subcommittee of The Endocrine Society, a member of the Obesity Task Force of the Endocrine Society, a member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration, a member of the Bay Area Board of Directors of the American Heart Association, and a member of the Steering Committee of Health Foods, Healthy Kids of the Culinary Institute of America. He also consults for several childhood obesity advocacy groups. Dr. Lustig lives in San Francisco with his wife Julie and two daughters. Spare time (what little there is) is spent cooking, theater-going, and traveling. To Contact Dr Robert Lustig, M.D.  go to robertlustig.com Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

WE'RE BACK! And with our Gatorback Review Show! The ATV Motocross National Championship returned to Gatorback forn the first time in 17 years and what ensued was arguably the craziest day in Pro Class racing in as long as we can remember! From the highest of highs, like Bryce Ford winning his first career moto and overall victory as a professional, to the lowest of lows like injuries for Chad Wienen, Zack Decker, Kevin Saar, and Cesar Jimenez. Gatorback was great and terrible all wrapped into one. Listen as event winner and new series point leader Bryce Ford, 52-time podium finisher Thomas Brown, and SSI Decals' Ian Harris help us break down all the craziness right here on the Digging Deep ATVMX Podcast! As always, thanks for DIGGING DEEP with us! Support the show

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Critical and Thinking features comedians Ty Barnett and Ian Harris. The show is streamed live on Facebook every Thursday at noon(ish). Follow us on facebook here Episodes are released on all podcast platforms the following Monday. Questions or comments? Message us on Facebook https://www.facebook.com/Criticalandthinking

Sam and Sarah are joined by special guest IAN HARRIS to discuss the pre-merge of Survivor Michigan: All Stars --- Support this podcast: https://anchor.fm/keepyourtorchlit/support

Partial anomalous pulmonary venous return refers to anomalies in which one or more (but not all) of the pulmonary veins connects to a location other than the left atrium. This causes left to right shunting which may have hemodynamic and therefore clinical significance, warranting repair in some patients. Join CardioNerds to learn about partial anomalous pulmonary venous return! Dr. Dan Ambinder (CardioNerds co-founder), Dr. Josh Saef (ACHD FIT at the University of Pennsylvania and ACHD Series co-chair), and Dr. Tripti Gupta (ACHD FIT at Vanderbilt University and episode lead) learn from Dr. Ian Harris (Director of the Adult Congenital Heart Disease program at University of California, San Francisco). Audio editing by CardioNerds Academy Intern, student doctor Shivani Reddy. The CardioNerds Adult Congenital Heart Disease (ACHD) series provides a comprehensive curriculum to dive deep into the labyrinthine world of congenital heart disease with the aim of empowering every CardioNerd to help improve the lives of people living with congenital heart disease. This series is multi-institutional collaborative project made possible by contributions of stellar fellow leads and expert faculty from several programs, led by series co-chairs, Dr. Josh Saef, Dr. Agnes Koczo, and Dr. Dan Clark. The CardioNerds Adult Congenital Heart Disease Series is developed in collaboration with the Adult Congenital Heart Association, The CHiP Network, and Heart University. See more Disclosures: None Pearls • Notes • References • Guest Profiles • Production Team CardioNerds Adult Congenital Heart Disease PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls - Partial Anomalous Pulmonary Venous Return (PAPVR) What is partial anomalous pulmonary venous return (PAPVR)? PAPVR refers to anomalies in which one or more (but not all) of the pulmonary veins connects to a location other than the left atrium. Often, this means one or more pulmonary veins empty into the right atrium or a systemic vein such as the superior vena cava or inferior vena cava. Physiologically, this produces a left-to-right shunt, allowing for already-oxygenated blood to recirculate into the lungs and result in excessive pulmonary blood flow.  What are the clinical features of PAPVR?Diagnosis is usually incidental on a cross sectional imaging such as CTA or CMR.The most common associated lesion is an atrial-level defect.It is unusual for a single anomalous pulmonary venous connection of only 1 pulmonary lobe to result in significant shunting. Patients with a significant degree of left to right shunting may have right heart dilatation or symptoms of dyspnea on exertion. When are some strategies for managing patients with PAPVR?A surgical correction is recommended for patients with PAPVR when functional capacity is impaired and RV enlargement is present, there is a net left-to-right shunt sufficiently large to cause physiological sequelae (aka: ratio of pulmonary flow (Qp) to systemic flow (Qs) is > 1.5:1), PA systolic pressure is less than 50% systemic pressure and pulmonary venous resistance is less than one third of systemic venous resistance.Surgical repair involves intracaval baffling of the left atrium (Warden procedure) or direct reimplantation of the anomalous pulmonary vein into the left atrium.Pregnancy is well tolerated in patients with repaired PAPVR. In patients with unrepaired lesion who may have right sided heart dilatation and/or pulmonary hypertension, preconception evaluation and counseling should address how pregnancy may affect mother's and fetus's health. Antibiotic prophylaxis for infective endocarditis is typically not needed unless patients are less than 6 months from recent surgery, have residual defect at the patch margin or prior history of infective endocarditi...